GALNT14 and pharynx cancer: Analysis of the data from the GPL570 platform (HG-U133 plus 2) showed that the expression of GALNT14 mRNA was also not different in pharyngeal cancer tissues, but was lower in head and neck cancer and oral cancer tissues compared to that in the unpaired normal tissues (Figure 2d).